Start Date
September 30, 2007
Primary Completion Date
January 31, 2008
Study Completion Date
January 31, 2008
NBI-34060
10 mg capsules; dosed as needed for falling back asleep after a bothersome awakening provided there are at least 4 hours remaining in bed; no more than one dose per night.
Clinilabs, Inc., New York
Sleep Disorders Center of Georgia, Atlanta
Community Research, Cincinnati
Tri-State Sleep Disorders Center, Cincinnati
Lead Sponsor
Neurocrine Biosciences
INDUSTRY